10x Insights
Loading account…
Companies / Health Care / Heartflow, Inc.
HTFL

Heartflow, Inc.

Health CareSurgical & Medical Instruments
Ticker HTFLSAN FRANCISCO, CAFiscal year ends DecemberBook value per share $3.25Diluted shares 86.0M

Heartflow, Inc. (Nasdaq: HTFL) provides software and artificial intelligence for non-invasive diagnosis and management of coronary artery disease. Its cloud-based Heartflow Platform analyzes coronary computed tomography angiography scans using AI and computational fluid dynamics to create patient-specific 3D heart… From the company’s description.

In fiscal 2025, Heartflow, Inc. reported revenue of $176.03M and a net loss of $116.79M. Its operating margin was −36.4%, and operations used $54.02M in cash. Over the twelve months to Jun 30, 2026, revenue was $212.07M.

Fiscal year 2025 · ends 12-31The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$176.03MFY2025
Last 12 mo $212.07M
-36.39%FY2025
Last 12 mo -37.84%
$-116.79MFY2025
Last 12 mo $-118.37M
-38.85%FY2025
Last 12 mo -42.32%
Cash & financing
$-54.02MFY2025
Last 12 mo $-52.23M
$-59.05MFY2025
Last 12 mo $-59.18M
—
36.9MFY2025
Last 12 mo 86.0M

Dotted labels explain each measure. is shown separately from the annual figures.

What Heartflow, Inc. does

In the company’s own words

Heartflow, Inc. (Nasdaq: HTFL) provides software and artificial intelligence for non-invasive diagnosis and management of coronary artery disease. Its cloud-based Heartflow Platform analyzes coronary computed tomography angiography scans using AI and computational fluid dynamics to create patient-specific 3D heart models and quantify blood flow, stenosis, plaque volume and plaque composition. Its products include Heartflow FFRCT Analysis, which assesses blood-flow restriction; Heartflow Plaque Analysis, which characterizes and measures coronary plaque; and Heartflow RoadMap Analysis, which supports CCTA interpretation and physician workflows. The company primarily serves hospitals and outpatient imaging accounts, with physicians selecting analyses for individual patients and the company generally charging on a pay-per-use basis. FFRCT Analysis accounted for 98% of revenue in 2025. As of December 31, 2025, the platform had been used to assess more than 600,000 patients and was deployed at more than 1,465 U.S. accounts.

Company details
Sector
Health Care
Industry (SIC)
Surgical & Medical Instruments
Headquarters
SAN FRANCISCO, CA
Fiscal year end
December
CIK
1464521
SIC
3841

Financial performance, year by year

Fiscal 2025–2025 · USD
$-151.42M$-52.28M$46.85M$145.98M$245.12M2025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Heartflow, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

216
funds hold it
0 of 35
superinvestors hold it
$984.11M
held by funds, at market
38.1%
of shares held by funds

Largest fund holders · Heartflow, Inc.’s weight in each

VANGUARD HEALTH CARE FUND
VGHCX · VANGUARD SPECIALIZED FUNDS
—of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.07%of fund net assets
VANGUARD SMALL-CAP INDEX FUND
VB · VANGUARD INDEX FUNDS
0.03%of fund net assets
BARON DISCOVERY FUND
BDFFX · BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)
2.57%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Heartflow, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Heartflow, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Heartflow, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.